Binimetinib (Mektovi)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 18:22, 25 December 2015 by Jwarner (talk | contribs) (Created page with "=Mechanism of action= From the [http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=653635 NCI Drug Dictionary]: An orally available inhibitor of mitogen-activat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

From the NCI Drug Dictionary: An orally available inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) with potential antineoplastic activity. Binimetinib, noncompetitive with ATP, binds to and inhibits the activity of MEK1/2.

Also known as

ARRY-162, ARRY-438162

Retrieved from "https://hemonc.org/w/index.php?title=Binimetinib_(Mektovi)&oldid=9825"